News

Birmingham leads UK-wide biobank in rare eye disease

A Birmingham-based Consultant Ophthalmologist and researcher, Professor Alastair Denniston, has won funding to set up a UK-wide resource to aid research into a rare disease which can lead to blindness. Two charities – Fight for Sight and the Birdshot Uveitis Society – are jointly funding the research to improve understanding of the rare, sight-threatening disease, known as Birdshot Chorioretinopathy. This funding will help establish a national biobank and registry for Birdshot Chorioretinopathy, helping patients and … Continue reading “Birmingham leads UK-wide biobank in rare eye disease”

NIHR Trauma Management MedTech Co-operative holds celebratory launch event

The NIHR Trauma Management MedTech Co-operative (Trauma MIC) officially launched on Wednesday 7 February with an all-day event at the Institute of Translational Medicine (ITM), based on the Queen Elizabeth Hospital Birmingham (QEHB) site. The Trauma MIC, formerly known as the NIHR Trauma Management Healthcare Technology Co-operative (HTC) from 2012 to 2017, will continue to facilitate innovation in the medical technologies sector for trauma patients. The launch event featured a variety of speakers and was … Continue reading “NIHR Trauma Management MedTech Co-operative holds celebratory launch event”

Ground breaking research for liver patients could be the biggest trial of its type ever

A consultant liver physician at University Hospitals Birmingham NHS Foundation Trust has been awarded a £2.3 million research grant to lead a clinical trial as Chief Investigator. Dr Dhiraj Tripathi will be heading up the ground breaking trial which aims to save lives and essential NHS funds. Currently, liver disease is the fifth biggest killer in the UK and deaths are amongst relatively young patients. A complication of diseases of the liver is internal bleeding, … Continue reading “Ground breaking research for liver patients could be the biggest trial of its type ever”

Encouraging findings presented for potential new Sjögren’s treatment

The results of a Phase IIa clinical trial have suggested a potential new antibody treatment for patients suffering from Sjögren’s syndrome. The trial was sponsored by Novartis and run in conjunction with the NIHR Translation Research Collaboration (TRC) in joint and inflammatory diseases. It is thought that up to 500,000 people in the UK, mainly women, suffer from Sjögren’s syndrome, which is caused when the body’s immune system attacks glands that secrete fluid, such as … Continue reading “Encouraging findings presented for potential new Sjögren’s treatment”

£54 million funding to transform health through data science

Birmingham Health Partners will lead one of six new sites across the UK created to address challenging healthcare issues through use of data science, funded by £30 million from Health Data Research UK. The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust will form part of the Midlands site, together with the Universities of Leicester, Nottingham and Warwick. The other five sites will be based in Cambridge, London, Oxford, Scotland and Wales/Northern Ireland. … Continue reading “£54 million funding to transform health through data science”